Frederick G. Vogt - 14 May 2025 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role
Interim CEO & General Counsel, Director
Signature
/s/ Frederick G. Vogt
Issuer symbol
IOVA
Transactions as of
14 May 2025
Transactions value $
$42,250
Form type
4
Filing time
16 May 2025, 16:05:18 UTC
Previous filing
07 Mar 2025
Next filing
04 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Vogt Frederick G Interim CEO & General Counsel, Director C/O IOVANCE BIOTHERAPEUTICS, INC., 825 INDUSTRIAL ROAD, SUITE 100, SAN CARLOS /s/ Frederick G. Vogt 16 May 2025 0001719678

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IOVA Common Stock Purchase $42,250 +25,000 +7.2% $1.69 374,646 14 May 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were acquired in the open market during a permitted trading window in accordance with the Issuer's Insider Trading Policy. A copy of the Insider Trading Policy is filed as Exhibit 19.1 to the Issuer's Annual Report on Form 10-K for the year ended December 31, 2024.